Home
Lumen Bioscience

Lumen Bioscience Market Share Analysis for August 2026

Discover how Lumen Bioscience is transforming biologic drug manufacturing using algae, offering unprecedented scalability, cost-effectiveness, and sustainability.

Industry: N/A

Domainlumen.bio

Year Founded2017

Employees51 - 200

Annual Revenue$10M - $15M

Lumen Bioscience

Lumen Bioscience (including company regionals)

lumen.bio

See more website traffic and engagement information

Lumen Bioscience Revenue up to August 2026 is 10M - 15M

revenue generated by Lumen Bioscience top domains

Lumen Bioscience top domains revenue over 3 years

Revenue for Lumen Bioscience top domains

lumen.bio10M - 15M

See more with Sales Intelligence

Total visits to Lumen Bioscience's top domains

Understand Lumen Bioscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

lumen.bio5K

See more with Sales Intelligence

Avg. visit duration in Lumen Bioscience's top domains

Analyze Lumen Bioscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

lumen.bio00:00:36

See more with Sales Intelligence

Avg. pageviews on Lumen Bioscience's top domains

See how Lumen Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

lumen.bio2.09

See more with Sales Intelligence

Lumen Bioscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Lumen Bioscience

These are the website technologies, by industry, used by Lumen Bioscience top domains

Content Management System (5)

WordPress

Email Services (3)

Microsoft Exchange Online

Social (3)

Instagram

Audio Video Media (2)

Podbean

More Technologies

7

See all

News & Signals from Lumen Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLumen Bioscience, Inc. receives financing of $7M.Seattle-based Lumen Bioscience has been awarded up to $7M from the Department of War to support Phase 1 clinical development of LMN-1001, a host directed, investigational intranasal antiviral candidate.

NewsLumen receives financing of $30M in Series C1.Lumen Bioscience raises $30M Series C extension.